|
Delayed
Berne S.E.
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | - |
| 25/09 | DocMorris AG : Receives a Buy rating from Deutsche Bank | ZD |
| 23/09 | Court hears case over dm mail-order pharmacy | DP |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 625.6 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 116.33% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 827.4 | 862.5 | 858.3 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 93.88% | 4.24% | -0.49% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -7.74x | -17.6x | -259x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.93x | 2.07x | 2.06x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.3x | 2.8x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.5x | 0.44x | 0.41x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.66x | 0.61x | 0.56x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -48.6x | 38.8x | 16.4x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -13.2x | -36.6x | 188x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -10.4x | -24.4x | -59.6x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -9.62% | -4.09% | -1.68% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.601 | -0.705 | -0.0478 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,262 | 1,408 | 1,541 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -17.01 | 22.26 | 52.35 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -62.84 | -23.58 | 4.555 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -85.94 | -41.26 | -13.31 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 201.8 | 236.9 | 232.7 |
| Reference price 2 | 235.50 | 25.56 | 73.75 | 19.98 | 5.95 | 12.39 | 12.39 | 12.39 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 50,489 | - | - |
| Announcement Date | 24/03/22 | 24/03/23 | 20/03/24 | 12/03/25 | 18/03/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.21x | 0.64x | 9.51x | -.--% | 1.46TCr | |
| 16.1x | 0.72x | 7.5x | 2.31% | 605.5Cr | |
| 18.95x | 0.71x | 12.02x | 1.13% | 581.99Cr | |
| 14.47x | 0.88x | 6.18x | 2.92% | 415.71Cr | |
| 14.27x | 1.23x | 7.5x | 5.67% | 314.87Cr | |
| 14.8x | 0.89x | 6.68x | 4.39% | 304.3Cr | |
| 13.63x | 0.57x | 4.41x | 5.3% | 302.59Cr | |
| 33.34x | - | - | - | 257.68Cr | |
| Average | 17.72x | 0.80x | 7.69x | 3.1% | 530.95Cr | |
| Weighted average by Cap. | 17.01x | 0.75x | 8.46x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
